Both in Electromedical Equipment
ENDRA Life Sciences vs Nexalin Technology
Over the past year NDRA returned −10.1% and NXL returned −96.3%; their daily moves had a correlation of -0.04.
NDRA −10.1% NXL −96.3%Growth of $1, one year, split-adjusted
| Metric | NDRA | NXL |
|---|---|---|
| Price | $4.74 | $1.63 |
| Market cap | $7.1M | $1.7M |
| Today | −4.45% | −0.61% |
| 1 month | −19.4% | −62.5% |
| 6 months | −2.3% | −84.3% |
| Year to date | +4.6% | −90.3% |
| 1 year | −10.6% | −96.3% |
| Revenue growth (YoY) | — | −82.8% |
| Gross margin | — | 73.2% |
| Net margin | — | −18412.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.9× |
| Net cash | $1.7M | $1.0M |
| Dividend yield | — | — |
| Volatility (60d) | 86.3% | 1,001.5% |
| Short % of float | 1.7% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).